In participants with type 2 diabetes, the average A1C reduction of 2.02% by week 48 is clinically significant enough that many would qualify for medication reduction under physician guidance
Sigma-Aldrich, Cat
The Semaglutide cohort compared to the non-GLP-1RA anti-obesity medications cohort was older, had a lower prevalence of adverse socioeconomic determinants of health, mental disorders, and substance use disorders, and a higher prevalence of morbid obesity, T2D and obesity-associated comorbidities
Semaglutide helps control your appetite, but its up to you to choose the right foods
SURMOUNT-1 enrolled 2,539 adults with a mean baseline BMI of 38.0, and 94.5% of participants had a BMI of 30 or higher
In rare cases, you may need to be hospitalized